Начало › Лимфом › Ню Йорк › New York City
Клинични проучвания за Лимфом в New York City, NY
33 проучвания за Лимфом търсят участници в обекти в и около New York City (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Набиране на участнициФаза 1
- Columbia University, New York
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Набиране на участнициФаза 1
- Memorial Sloan Kettering Cancer Center, New York
Epco, Zanu, Ritux for R/R FL or MZL
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center, New York
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center, New York
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
Набиране на участнициФаза 1
- Memorial Sloan Kettering Cancer Center, New York
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Набиране на участнициФаза 1
- Cornell, New York
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Набиране на участнициФаза 1/2
- Research Site, New York
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Набиране на участнициФаза 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
Набиране на участнициФаза 1
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Набиране на участнициФаза 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center, New York
DALY II USA/ MB-CART2019.1 for DLBCL
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
Набиране на участнициФаза 1
- Memorial Sloan Kettering, New York
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Набиране на участнициФаза 1/2
- Call for Information (Investigational Site 0031), New York
CD4CAR for CD4+ Leukemia and Lymphoma
Набиране на участнициФаза 1
- Albert Einstein Health Network, New York
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Набиране на участнициФаза 1/2
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)
Набиране на участнициФаза 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Набиране на участнициНаблюдателно проучване
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
Набиране на участнициФаза 2
- Columbia University Irving Medical Center, New York
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Набиране на участнициЗдравите доброволци са добре дошли
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Набиране на участнициФаза 1/2
- Mt Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of CAR-T Therapy in Older Patients
Набиране на участнициНаблюдателно проучване
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Набиране на участнициФаза 2
- Memorial Sloan Kettering, New York
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
Набиране на участнициФаза 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Набиране на участнициНаблюдателно проучване
- Memorial Sloan Kettering Cancer Center, New York
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
Набиране на участнициФаза 2
- Memorial Sloan Kettering Cancer Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Memorial Sloan Kettering Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Набиране на участници
- Columbia University, New York
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)
Набиране на участнициФаза 1
- Columbia University Irving Medical Center, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Набиране на участници
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Проучвания за Лимфом в други градове
- Houston, TX34 проучвания
- Boston, MA33 проучвания
- Washington, DC23 проучвания
- Baldwin Park, CA21 проучвания
- Chicago, IL20 проучвания
- Durham, NC17 проучвания
- St. Louis, MO15 проучвания
- Philadelphia, PA15 проучвания
- Cleveland, OH14 проучвания
- Edison, NJ12 проучвания
- Atlanta, GA12 проучвания
- Seattle, WA12 проучвания
Други проучвания в New York City
- Рак на гърдата136 проучвания
- Рак на белия дроб с недребноклетъчен тип121 проучвания
- Рак (всички видове)109 проучвания
- Рак на простатата103 проучвания
- Метастатичен рак93 проучвания
- Колоректален рак78 проучвания
- Рак на яйчниците69 проучвания
- Рак на белия дроб60 проучвания
- Множествен миелом60 проучвания
- Рак на панкреаса60 проучвания
- Ендометриален рак52 проучвания
- Остра миелоидна левкемия51 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.